Reciprocal relationship from ABBV graph: Reciprocal relationship from ALDX graph: Outside of the United States, the Company would be eligible to receive tiered royalties on net sales of reproxalap.
Aldeyra Therapeutics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
ALDX-DEBT-7669
Warrants outstanding: 211528
90%
xbrl warrant detail from xbrl 2018-12-31.
ALDX-DEBT-7670
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2014-12-31.
ALDX-DEBT
Debt stack $15.5M
90%
Market cache reports total debt of $15.5M.
Aldeyra Therapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Aldeyra Therapeutics, Inc..
Aldeyra Therapeutics, Inc. Ownership
Holder
Name
Confidence
Evidence
ALDX-OWNER-KNOLL-CAPITAL-MANAGEMENT-LLC
Knoll Capital Management, LLC
90%
13F overlay lists Knoll Capital Management, LLC as top holder; 125 tracked holders.
Aldeyra Therapeutics, Inc. Extended Supply Chain Network